Metabolism Ignite Results backed by 9 independent clinical studies
Based on independent studies on key ingredients of Metabolism Ignite. Metabolism Ignite uses ingredients at the clinical dosage levels in the studies below. All studies showed no adverse effects of the polyphenolic extracts, hibiscus and lemon verbena, in Metabolaid.
CLINICAL STUDY 1
Summary: A double-blind, randomized, placebo-controlled study that assessed the effects of a combination of hibiscus and lemon verbena extracts in overweight/obese subjects.
Participants: 55 women studied over the course of 2 months found no adverse side effects.
Key results:
-
Activated AMPK by 150%
-
Average 8-10 lbs weight loss
-
Decreased heart rate, blood pressure and cholesterol
CLINICAL STUDY 2
Summary: A double-blind, randomized, placebo-controlled study that assessed the effects of hibiscus and lemon verbena extracts on appetite-related biomarkers in overweight subjects.
Participants: 54 women studied over the course of 2 months found no adverse side effects.
Key results:
-
Average 8 lbs weight loss
-
Decreased body fat, heart rate, and blood pressure
-
Subjects reported feeling less hungry, more satisfied, more full and felt they could eat less.
CLINICAL STUDY 3
Summary: A double-blind, placebo-controlled study to determine the effectiveness of hibiscus and lemon verbena extracts in the reduction of body fat mass in healthy subjects.
Participants: 84 subjects studied over the course of 12 weeks. No dietary changes were made.
Key results:
-
Average 5 lbs fat loss, without loss in muscle mass
-
Fat loss concentrated in torso or visceral fat
-
Decreased cholesterol and LDL levels
CLINICAL STUDY 4
Summary: A 9 week study found that the Metabolaid combination of hibiscus and lemon verbena extracts prevents high-fat, diet-induced obesity through the activation of the AMPK pathway.
Participants: 8 week old male mice studied over the course of 9 weeks.
Key Results:
-
Body size, weight, and weight gain were significantly lowered
-
Food-efficiency ratio was significantly lowered
-
Reduced liver weight
CLINICAL STUDY 5
Summary: A randomized, double-blind, placebo-controlled trial to determine the effectiveness of hibiscus and lemon verbena extracts for reducing blood pressure in pre-hypertensive and type 1 hypertensive subjects.
Participants: 80 prehypertensive or type 1 hypertensive subjects, male and female between the ages of 18-65 were studied over the course of 84 days.
Key Results:
-
Decreased systolic blood pressure by 3%
CLINICAL STUDY 6
Summary: A randomized, double-blind, placebo-controlled study to determine the effects of Metabolaid on pre- and stage 1 hypertensive patients.
Participants: 84 pre-hypertensive and early stage 1 hypertensive patients were studied over the course of 6 weeks.
Key Results:
-
Significant decrease in fat percentage
-
Significant weight reduction
-
Improved systolic blood pressure
CLINICAL STUDY 7
Summary: A randomized, double-blind, cross-over, placebo-controlled study to determine the effectiveness of the polyphenolic extract, hibiscus and lemon verbena, on appetite regulation in overweight or obese grade 1 subjects.
Participants: 33 overweight or obese subjects (36 participated, 33 were included in analysis) both male and female, ages 18-65, were studied over the course of 150 days (divided into two 60 day periods, separated by a 30-day wash out period).
Key Results:
-
Decrease in appetite sensation
-
Decrease in satiety
-
Consumption of less calories
-
Reduction in fat mass
CLINICAL STUDY 8
Summary: This study involved the inclusion of a mobile app with daily reminders and healthy lifestyle recommendations in addition to a wearable fitness device and dietary supplement, Metabolaid.
Participants: 37 subjects, over the age of 18 were studied from September 2020 to April 2021.
Key Results:
-
Significant reduction in body weight and BMI after 90 days for those in the app group, and a significant decrease in body fat percentage and visceral fat after 2 months.
-
4.27% decrease in blood pressure for those in the app group.
-
Significant differences were observed in both groups in abdominal measurements and skin folds. The waist, hip, triceps, biceps, and subscapular measurements were all significantly reduced.
CLINICAL STUDY 9
Summary: This study determined whether Metabolaid has beneficial effects on the human gut microbiota.
Participants: Fecal samples from 2 subjects were studied over the course of 72 hours.
Key Results:
-
Metabolaid seems to modulate the gut microbiome in a dose-dependent manner, leading to an increase in the relative abundances of some major genera.
-
Metabolaid has some gut microbiota-modulating properties that could contribute to some of the beneficial effects of this supplement in regards to obesity.
*Based on independent clinical studies on key ingredients in Metabolism Ignite